Author

Anne M. Robinson 1

1 Abbvie Inc., North Chicago, United States

A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Wan J Le

ADALILMUMAB SERUM CONCENTRATION AS A PREDICTOR FOR CLINICAL EFFICACY - ROC ANALYSES

Nael M. Mostafa, Anne M. Robinson, Shringi Sharma, William Sandborn, Subrata Ghosh, Stephen B Hanauer, Roopal B Thakkar, Walid Awni

ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY

Edward V Loftus Jr, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Sofie Berg, Gabriela Alperovich, Mareike Bereswill, Jasmina Kalabic, Martha Skup, Joel Petersson, Anne M. Robinson

ASSESSMENT OF IMPACT III WELL-BEING DOMAIN SCORES IN ADALIMUMAB-TREATED PAEDIATRIC PATIENTS WITH CROHN'S DISEASE

Amy Grant, Anthony R. Otley, Johanna Caroline Escher, Jeffrey S Hyams, Jen-Fue Maa, Gabriela Alperovich, Andreas Lazar, Anne M. Robinson, Anthony W. Wang, Samantha Eichner

BURDEN OF DISEASE IN PAEDIATRIC PATIENTS WITH MODERATE VERSUS SEVERE CROHN’S DISEASE IN THE IMAGINE 1 TRIAL

Frank Ruemmele, Jeffrey S Hyams, Joel Rosh, Marla C. Dubinsky, James Markowitz, Anne Griffiths, Dan Turner, Samantha Eichner, Andreas Lazar, Anne M. Robinson, Bidan Huang, Roopal B Thakkar

CLINICAL BENEFIT OF ADALIMUMAB DOSE ADJUSTMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE IN EXTEND

Jean-Frederic Colombel, Paul Rutgeerts, William Sandborn, Douglas C. Wolf, Walter Reinisch, Gert Van Assche, Samantha Eichner, Joel Petersson, Anne M. Robinson, Roopal B Thakkar

CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY

Silvio Danese, William Sandborn, Edward V. Loftus Jr., Stephen B Hanauer, Stefan Schreiber, Laurent Peyrin-Biroulet, Remo Panaccione, Julian Panés, Filip Baert, Jean-Frederic Colombel, Marc Ferrante, Edouard Louis, Alessandro Armuzzi, Sasikiran Goteti, John Liu, Nael M. Mostafa, Thao Doan, Joel Petersson, Anne M. Robinson

CONCORDANCE OF STOOL FREQUENCY AND ABDOMINAL PAIN MEASURES WITH SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASE

James D Lewis, Paul Rutgeerts, Geert R. D'Haens, Jean-Frederic Colombel, William Sandborn, Walter Reinisch, James Butler, Jen Fue Maa, Anne M. Robinson

CORRELATION BETWEEN ENDOSCOPIC AND HISTOLOGICAL HEALING IN ADULTS WITH MODERATE TO SEVERE CROHN?S DISEASE: DATA FROM EXTEND

Walter Reinisch, Jean-Frederic Colombel, Paul Rutgeerts, Karel Geboes, Geert R. D'Haens, Joel Petersson, Samantha Eichner, Jen-Fue Maa, Anne M. Robinson

DIFFERENT METHODOLOGIES FOR DETERMINING MAYO SCORE IN CLINICAL STUDIES CAN INFLUENCE DISEASE ACTIVITY ASSESSMENTS IN ULCERATIVE COLITIS

Subrata Ghosh, William Sandborn, Julian Panés, Geert R. D'Haens, Nattanan Reilly, Andreas Lazar, Bidan Huang, Anne M. Robinson, Roopal B Thakkar

Item 1 - 10 / 36
1
2 3 4